Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Mucosal Melanoma”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06041724
What this trial is testing

Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma

Who this might be right for
Advanced Mucosal Melanoma
Fudan University 46
Testing effectiveness (Phase 2)UnknownNCT03941795
What this trial is testing

Phase II Study in the Treatment of Patients With Advanced Mucinous Melanoma

Who this might be right for
Advanced Mucosal Melanoma
Peking University Cancer Hospital & Institute 99
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07236528
What this trial is testing

Combination of Carilizumab, Apatinib, and Radiotherapy for Advanced Mucosal Melanoma

Who this might be right for
Mucosal Melanoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06999980
What this trial is testing

Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)

Who this might be right for
Cutaneous MelanomaMucosal Melanoma
Melanoma Institute Australia 494
Large-scale testing (Phase 3)Looking for participantsNCT05549297
What this trial is testing

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Who this might be right for
Advanced Melanoma
Immunocore Ltd 540
Early research (Phase 1)Ended earlyNCT02346955
What this trial is testing

Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)

Who this might be right for
Non-small Cell Lung Carcinoma (NSCLC)MelanomaBladder Cancer+3 more
Famewave Ltd. 27
Testing effectiveness (Phase 2)Ended earlyNCT02978443
What this trial is testing

A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab

Who this might be right for
Acral Lentiginous MelanomaMucosal Melanoma
Georgetown University 14
Testing effectiveness (Phase 2)Study completedNCT01827111
What this trial is testing

Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT03986515
What this trial is testing

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Who this might be right for
Mucosal MelanomaAdvanced CancerApatinib+1 more
Henan Cancer Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01119508
What this trial is testing

Ipilimumab + Temozolomide in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)WithdrawnNCT03220009
What this trial is testing

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Who this might be right for
Cervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)WithdrawnNCT03758729
What this trial is testing

Phase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma.

Who this might be right for
Melanoma
Samsung Medical Center
Testing effectiveness (Phase 2)UnknownNCT04472806
What this trial is testing

Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

Who this might be right for
Mucosal Melanoma
Fudan University 31
Testing effectiveness (Phase 2)Ended earlyNCT01864538
What this trial is testing

Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
ImmunoGenesis 11
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableLooking for participantsNCT07215988
What this trial is testing

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

Who this might be right for
Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8+5 more
Ohio State University Comprehensive Cancer Center 70
Testing effectiveness (Phase 2)Study completedNCT03033576
What this trial is testing

Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Melanoma of Unknown Primary+3 more
National Cancer Institute (NCI) 94
Testing effectiveness (Phase 2)WithdrawnNCT02535078
What this trial is testing

Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma

Who this might be right for
Malignant Melanoma
Immunocore Ltd
Load More Results